Thus, specific targeting of IGF-1R signaling post development may prove to be the best approach to achieve the benefits of low growth signals on healthspan and aging, without the potential unwanted side effects of combined adult-onset GH/IGF-1 deficiency
Importantly, they will keep them affordable (no increase in price) and limit compounded GLP-1s for rare (FDA-compliant) cases," FDA commissioner Marty Makary wrote in a post on X
Glucagon-like peptide-1 receptor agonists: A systematic review of comparative effectiveness research
Aspirin may retain a role in select inflammatory or hereditary risk settings, while GLP-1 agents could become foundational for metabolically driven risk reduction
By now Holst had joined them as a consultant (Molteni, Chen)
They have absolutely no idea whats in it, how much is in it, and where its coming from